160 related articles for article (PubMed ID: 8397370)
1. Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma.
Yano T; Sander CA; Clark HM; Dolezal MV; Jaffe ES; Raffeld M
Oncogene; 1993 Oct; 8(10):2741-8. PubMed ID: 8397370
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus and Burkitt's lymphoma.
Magrath I; Jain V; Bhatia K
Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792
[TBL] [Abstract][Full Text] [Related]
3. Level of MYC overexpression in pediatric Burkitt's lymphoma is strongly dependent on genomic breakpoint location within the MYC locus.
Wilda M; Busch K; Klose I; Keller T; Woessmann W; Kreuder J; Harbott J; Borkhardt A
Genes Chromosomes Cancer; 2004 Oct; 41(2):178-82. PubMed ID: 15287031
[TBL] [Abstract][Full Text] [Related]
4. [Epstein-Barr virus and Burkitt's lymphoma].
Joab I
Med Trop (Mars); 1999; 59(4 Pt 2):499-502. PubMed ID: 10901854
[TBL] [Abstract][Full Text] [Related]
5. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
[TBL] [Abstract][Full Text] [Related]
6. The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors.
Bhatia KG; Gutiérrez MI; Huppi K; Siwarski D; Magrath IT
Cancer Res; 1992 Aug; 52(15):4273-6. PubMed ID: 1638540
[TBL] [Abstract][Full Text] [Related]
7. Selective expression of one c-myc allele in two human myeloma cell lines.
Kuehl WM; Brents LA; Chesi M; Bergsagel PL
Cancer Res; 1996 Oct; 56(19):4370-3. PubMed ID: 8813127
[TBL] [Abstract][Full Text] [Related]
8. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas.
Bhatia K; Huppi K; Spangler G; Siwarski D; Iyer R; Magrath I
Nat Genet; 1993 Sep; 5(1):56-61. PubMed ID: 8220424
[TBL] [Abstract][Full Text] [Related]
9. Burkitt-like mutations in the c-myc gene locus in prolymphocytic leukemia.
Brennscheidt U; Eick D; Kunzmann R; Martens U; Kiehntopf M; Mertelsmann R; Herrmann F
Leukemia; 1994 May; 8(5):897-902. PubMed ID: 8182948
[TBL] [Abstract][Full Text] [Related]
10. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
[TBL] [Abstract][Full Text] [Related]
11. c-myc gene abnormalities in mucosa-associated lymphoid tissue (MALT) lymphomas.
Peng H; Diss T; Isaacson PG; Pan L
J Pathol; 1997 Apr; 181(4):381-6. PubMed ID: 9196434
[TBL] [Abstract][Full Text] [Related]
12. Retinoblastoma-related geneRb2/p130 are rarely mutated in Burkitt's lymphoma from Brazil.
Klumb CE; Magluta EP; Rezende LM; Apa AG; Alonso JF; Maia RC
Am J Hematol; 2007 Mar; 82(3):238-9. PubMed ID: 16955460
[TBL] [Abstract][Full Text] [Related]
13. [Molecular analysis in Argentinian patients with Burkitt's lymphoma].
Gutiérrez MI; Barriga F; Díez B; Larripa I; Magrath I
Sangre (Barc); 1990 Feb; 35(1):10-4. PubMed ID: 2159189
[TBL] [Abstract][Full Text] [Related]
14. Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines.
Albert T; Urlbauer B; Kohlhuber F; Hammersen B; Eick D
Oncogene; 1994 Mar; 9(3):759-63. PubMed ID: 8108117
[TBL] [Abstract][Full Text] [Related]
15. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas.
Clark HM; Yano T; Otsuki T; Jaffe ES; Shibata D; Raffeld M
Cancer Res; 1994 Jul; 54(13):3383-6. PubMed ID: 8012955
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.
Jochner N; Eick D; Zimber-Strobl U; Pawlita M; Bornkamm GW; Kempkes B
EMBO J; 1996 Jan; 15(2):375-82. PubMed ID: 8617212
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of MYC in common epithelial cancers and acute leukemias.
Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Lee JY; Yoo NJ; Lee SH
APMIS; 2006 Jun; 114(6):436-9. PubMed ID: 16856965
[TBL] [Abstract][Full Text] [Related]
19. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
20. Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9.
Kumar R; Angelini S; Hemminki K
Oncogene; 2003 Dec; 22(58):9217-24. PubMed ID: 14681681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
